D-1046-2016 Class III Terminated
FDA drug recall D-1046-2016 was initiated by Sandoz, Inc on May 2, 2016 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing. The recall status is terminated (terminated Aug 17, 2017).
Recall details
- Product Type
- Drugs
- Report Date
- Jun 29, 2016
- Initiation Date
- May 2, 2016
- Termination Date
- Aug 17, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Dicloxacillin Sodium Capsules USP, 500mg, Rx Only, 100 Capsule bottle, Manufactured in Austria by Sandoz Gmbh, Distributed by Sandoz Inc. , Princeton, NJ 08540, Product of Spain, NDC 0781-2258-01
Reason for recall
Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing.
Distribution pattern
Nationwide
Code information
Lot #: EN0389, EP0473, Exp. 8/2016 ; FA4834, FN2602, Exp. 2/2017; FW3646 , Exp.11/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1046-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026